Research progress on Livin protein: An inhibitor of apoptosis

Molecular and Cellular Biochemistry

Volumn 357, Issue 1-2, 2011, Pages 39-45

  Yan, Biao ^a  

^a SHANGHAI OCEAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer marker; Cancer therapy; Livin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA CATENIN; CANCER VACCINE; CASPASE 3; CASPASE 7; CASPASE 9; DOXORUBICIN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; LIVIN; MESSENGER RNA; RNA INDUCED SILENCING COMPLEX; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; BIRC7 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ADVANCED CANCER; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER PROGNOSIS; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CELLULAR DISTRIBUTION; CYTOPLASM; DNA DAMAGE; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; IMMUNE SYSTEM; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; NEUROBLASTOMA; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 84857434415     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0873-7     Document Type: Review

References (70)

1. Schimmer AD (2004) Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64:7183-7190 (Pubitemid 39372048)
2. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Bio 3(6):401-410 (Pubitemid 34685698)
3. Crook NE, Clem RJ, Miller LK (1993) An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67(64): 2168-2174 (Pubitemid 23088392)
4. Badran A, Yoshida A, Ishikawa K et al (2004) Identification of a novel splice variant of the human anti-apoptosis gene survivin. Biochem Bioph Res Co 314(313):902-907 (Pubitemid 38112885)
5. Eckelman BP, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7(10):988-994 (Pubitemid 44480512)
6. Roy N, Deveraux QL, Takahashi R et al (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 6(23):6914-6925 (Pubitemid 27520792)
7. Vaux DL, Silke J (2003) Mammalian mitochondrial IAP binding proteins. Biochem Bioph Res Co 304:499-504 (Pubitemid 36506522)
8. Wrzesie -Ku A, Smolewski P, Sobczak-Pluta A et al (2004) The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 9(6):705-715 (Pubitemid 40941199)
9. Uren AG, Coulson EJ, Vaux DL (1998) Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem Sci 23(25): 159-162 (Pubitemid 28261031)
10. Fraser AG, James C, Evan GI et al (1999) Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 9(6):292-302
11. Uren AG, Beilharz T, O'Connell MJ et al (1999) Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci USA 96(18):10170-10175 (Pubitemid 29422531)
12. Vucic D, Stennicke HR, Pisabarro MT et al (2000) ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10(21):1359-1366
13. Franklin MC, Kadkhodayan S, Ackerly Het al (2003) Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry 42(27):8223-8231 (Pubitemid 36858983)
14. Kasof GM, Gomes BC (2001) Livin, a novel inhibitor of apoptosis protein family member. J Bio Chem 276:3238-3246
15. Chang H, Schimmer AD (2007) Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther 6:24-30 (Pubitemid 46206665)
16. Ma L, Huang Y, Song Z (2006) Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ 13:2079-2088 (Pubitemid 44742691)
17. Lin JH, Deng G, Huang Q et al (2000) KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Bioph Res Co 279(273):820-831 (Pubitemid 32042862)
18. Ashhab Y, Alian A, Polliack A et al (2001) Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495:56-60 (Pubitemid 32367973)
19. Verhagen AM, Coulson EJ, Vaux DL (2001) Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2(7):3001-3009 REVIEWS3009
20. Hinds MG, Norton RS, Vaux DL et al (1999) Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol 6:648-651 (Pubitemid 29318954)
21. Deshaies RJ, Joazeiro CAP (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399-434
22. Silke J, Kratina T, Chu D et al (2005) Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci USA 102(145): 16182-16187 (Pubitemid 41688888)
23. Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of Livin, Survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14(11):85-90 (Pubitemid 36150264)
24. Yagihashi A, Asanuma K, Kobayashi D et al (2005) Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung Cancer 48(42):217-221
25. Boaz N, Itay L, Meital E et al (2007) Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin. Apoptosis 12(7):1129-1142
26. Nachmias B, Lazar I, Elmalech M et al (2007) Subcellular localization determines the delicate balance between the anti-and pro-apoptotic activity of Livin. Apoptosis 12(17):1129-1142 (Pubitemid 46890380)
27. Wagener N, Crnkovi Cacute I et al (2007) Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney. Brit J Cancer 97:1271-1276 (Pubitemid 350035816)
28. Yuan D, Liu L, Gu D (2006) Transcriptional regulation of livin by -catenin/TCF signaling in human lung cancer cell lines. Mol Cell Biochem 306:171-178
29. Dasgupta A, Peirce SK, Findley HW (2009) MycN is a transcriptional regulator of livin in neuroblastoma. Oncol Rep 22(24): 831-835
30. Vucic D, Deshayes K, Ackerly H et al (2002) SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Bio Chem 277:12275-12279 (Pubitemid 34952796)
31. Yang QH, Du C (2004) Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J Bio Chem 27:16963-16970 (Pubitemid 38560449)
32. Crnkovi-Mertens I, Semzow J, Hoppe-Seyler F (2006) Isoformspecific silencing of the Livin gene by RNA interference defines Livin as key mediator of apoptosis inhibition in HeLa cells. J Mol Med 83:232-240 (Pubitemid 43291012)
33. Abd-Elrahman I, Hershko K, Neuman T et al (2009) The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity. Cancer Res 69(13):5475-5480
34. Wang R, Lin F, Wang X et al (2008) Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells. Cancer Gene Ther 15:402-412 (Pubitemid 351693226)
35. Hao W, Sheng-Shun TAN, Xin-Yang W et al (2007) Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin 28(12):1968-1974
36. Lin-lin W, Zheng H, Wei-wei T et al (2009) Effects of livin gene silencing by siRNA on apoptosis and cell cycle of human malignant melanoma A375 cells. Tumor 29(24):345-349
37. Wang X, Xu J, Ju S et al (2010) Livin gene plays a role in drug resistance of colon cancer cells. Clin Biochem 43: 655-660
38. Qiuping Z, Jei X, Youxin J et al (2004) CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation. Cancer Res 64:7579-7587 (Pubitemid 39372103)
39. Choi J, Hwang YK, Sung KW et al (2007) Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 109(102): 471-477 (Pubitemid 46105940)
40. Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of Livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14(11):85-90 (Pubitemid 36150264)
41. Tanabe H, Yagihashi A, Tsuji N et al (2004) Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 46(43):299-304 (Pubitemid 39487304)
42. Hariu H, Hirohashi Y, Torigoe T et al (2005) Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Clin Cancer Res 11:1000-1009 (Pubitemid 40175747)
43. Kim DK, Alvarado CS, Abramowsky CR et al (2005) Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Pediatr Devel Pathol 8(6):621-629 (Pubitemid 41830922)
44. Xiang Y, Yao H, Wang S et al (2009) Prognostic value of survivin and livin in nasopharyngeal carcinoma. Laryngoscope 116(111):126-130 (Pubitemid 44383976)
45. Liu X, Chen N, Wang X et al (2006) Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. J Neuropathol Exp Neurol 65(69):905-913 (Pubitemid 44371236)
46. Gordon GJ, Mani M, Mukhopadhyay L et al (2007) Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. J Pathol 211:447-454 (Pubitemid 46332556)
47. Lopes RB, Gangeswaran R, McNeish IA et al (2007) Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer 120:2344-2352 (Pubitemid 46642120)
48. Nedelcu T, Kubista B, Koller A et al (2008) Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res Clin Oncol 2:237-244 (Pubitemid 350234069)
49. Crnković-Mertens I, Wagener N, Semzow J (2007) Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis. Cell Mol Life Sci 64:1137-1144 (Pubitemid 46684550)
50. Kempkensteffen C, Hinz S, Christoph F et al (2007) Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumor Biol 28:132-138 (Pubitemid 46975999)
51. Liu B, Han M, Wen JK et al (2007) Livin/ML-IAP as a new target for cancer treatment. Cancer Lett 250:168-176 (Pubitemid 46529441)
52. Stein CA, Cheng YC (1993) Antisense oligonucleotides as therapeutic agents: is the bullet really magical? Science 261: 1004-1012 (Pubitemid 23300859)
53. Hu YP, Cherton-Horvat G, Dragowska V et al (2003) Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9:2826-2836 (Pubitemid 36842129)
54. Tu SP, Jiang XH, Lin M et al (2003) Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res 63:7724-7732 (Pubitemid 37466703)
55. Xia C, Xu Z, Yuan X et al (2002) Induction of apoptosis in mesothelioma cells by anti-survivin oligonucleotides. Mol Cancer Ther 1:687-694
56. Puri N, Eller MS, Byers HR et al (2004) Telomere-based DNA damage responses: a new approach to melanoma. FASEB J 18: 1373-1381 (Pubitemid 39150352)
57. Kim DH, Rossi JJ (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet 8:173-184
58. Yamaguchi Y, Shiraki K, Fuke H et al (2005) Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand-and chemotherapeutic agent-induced cell death. Oncol Rep 14(15):1311-1316
59. Yonesaka K, Tamura K, Kurata T et al (2005) Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int J Cancer 118:812-820
60. Crnkovic-Mertens I, Hoppe-Seyler F, Butz K (2003) Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22:8330-8336 (Pubitemid 37485525)
61. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909-915 (Pubitemid 39273730)
62. Schmollinger JC, Vonderheide RH, Hoar KM (2003) Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction. Proc Natl Acad Sci USA 100:3398-3403 (Pubitemid 36356595)
63. Tsuruma T, Hata F, Torigoe T et al (2004) Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer. J Transl Med 2:19
64. Yagihashi A, Asanuma K, Tsuji N et al (2003) Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem 49: 1206-1208 (Pubitemid 36751117)
65. Schmollinger JC, Dranoff G (2004) Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy. Apoptosis 9:309-313 (Pubitemid 38981504)
66. Andersen MH, Becker JC, Straten P (2005) Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov 4:399-409 (Pubitemid 40704123)
67. Andersen MH, Reker S, Becker JC, Straten P (2004) The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses. J Invest Dermatol 22:392-399 (Pubitemid 38281060)
68. Andersen MH, Becker JC, Straten P (2004) Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP. J Invest Dermatol 122:1336-1337 (Pubitemid 38651114)
69. Crnkovi -Mertens I, Bulkescher J, Mensger C et al (2010) Isolation of peptides blocking the function of anti-apoptotic Livin protein. Cell Mol Life Sci 23:11-21
70. Lazar I, Yaacov B, Shiloach T et al (2010) The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. J Virol 84(81):639-646